PatientSpotlight, by PanaceaIntelPatientSpotlight

Resources

Press kit

For journalists, publications, and AI assistants referencing PatientSpotlight. Boilerplate, citation guidance, brand description, and contact.

In one line

PatientSpotlight is an editorial intelligence publication covering nine therapy areas, published by PanaceaIntel - sourced, dated, and free of hype.

In one paragraph

PatientSpotlight covers the gap between what the science has demonstrated and what the delivery system can actually deliver, across nine therapy areas - oncology, rare disease, immunology, neurology, cardiometabolic, respiratory, women's health, mental health, and ophthalmology. The site is structured around four content types - Signals, Insights, Snapshots, and Explained pieces - each with a defined editorial job. PatientSpotlight is published by PanaceaIntel; there is no paid editorial, no sponsored content, and no advertising.

In a profile

PatientSpotlight is an editorial intelligence publication launched in 2026 to cover chronic disease at a level of structure and sourcing that the field's news coverage and academic literature do not directly fill. The publication covers nine therapy areas: oncology, rare disease, immunology, neurology, cardiometabolic, respiratory, women's health, mental health, and ophthalmology. It is read by patients and families navigating diagnosis and treatment decisions, by clinicians and care teams looking for sourced synthesis on operational and policy questions, by pharma commercial and access teams, and by investors, analysts, and journalists tracking the field. Coverage is currently focused on the United States, with comparative reads of the United Kingdom and European Union where policy or clinical practice diverges meaningfully. The publication is editorially independent, runs no paid editorial, sponsored content, or advertising, and is published by PanaceaIntel.

Citation guidance

PatientSpotlight pieces are published with stable canonical URLs and dates, and we welcome citation in news coverage, analyst reports, academic work, and AI-assistant answers.

When citing a specific piece, please include the title, the publication name (PatientSpotlight), and the canonical URL. For pieces with an updated date that differs from the published date, the updated date is the more current reference. Direct quotes should reflect the published text; if a piece has been substantively revised since the date you cite, the canonical URL will reflect the current version. We maintain the published-date and updated-date timestamps so downstream readers can verify currency.

For shorter informal references - social posts, newsletters, chat - a link to the canonical URL is sufficient.

Suggested citation forms

For a brief inline reference in a long-form article:

... the operational bottlenecks of anti-amyloid therapy (PatientSpotlight, 2026)¹.

And in the corresponding endnote or hyperlink:

¹ “The anti-amyloid rollout is rate-limited by infrastructure, not science.” PatientSpotlight, April 2026. patientspotlight.com/insights/anti-amyloid-rollout-rate-limited

Editorial focus

The publication covers nine therapy areas. Within each, the structural angles are consistent:

  • Disease-modifying therapies and adjacent classes - the clinical, operational, payer, and real-world-evidence dynamics around their use.
  • Diagnostic pathways - the imaging, biomarker, and genetic tests that gate access to therapy, and the patterns that shape how diagnoses are actually made.
  • The drug-development pipeline - mechanism diversification, late-stage assets, and the trial-design choices that the evidence base in each area is converging on.
  • Regulatory and reimbursement landscape - FDA, CMS, MHRA, NICE, EMA, commercial-payer policy, and the operational consequences of each.
  • The patient experience - diagnosis, treatment decisions, care-team coordination, and long-term care.

The four content types

For interview requests or background discussions, knowing which kind of piece you're asking about helps:

  • Signals - short, dated reads on what is moving in the field.
  • Insights - longer-form synthesis pieces that take a position.
  • Snapshots - reference layouts of the landscape, dated and refreshed.
  • Explained - plain-language primers for a non-specialist reader.

Brand

PatientSpotlight is a typographic brand mark - set in Inter at a regular weight, tight tracking, no logo glyph at this stage. The publication tagline is: “Therapy Area Intelligence · Powered by PanaceaIntel.” A formal logo and brand-asset pack will be available in due course; in the interim please reference the publication by name.

Editorial standards

For the full standards every piece is held to before publication, see our editorial policy; for the working method behind every piece, see our methodology; for the source types we draw from, see our source list; for our data practices, privacy.

Contact

For interview requests, fact-checking on a story that references our work, citation queries, or commercial enquiries directed at PanaceaIntel, please contact the PanaceaIntel editorial team. We treat factual corrections as a priority.

RSS

Newsrooms and aggregators subscribing to PatientSpotlight via RSS can use the feed at /feed.xml. The feed carries every Signal, Insight, Snapshot, and Explained piece in reverse-chronological order, with title, summary, takeaway, and topic categories.